CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 149.4 SEK -0.53%
Market Cap: kr3.6B

Profitability Summary

CellaVision AB's profitability score is 59/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

59/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

59/100
Profitability
Score
59/100
Profitability
Score

Margins

Earnings Waterfall
CellaVision AB

Margins Comparison
CellaVision AB Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SE
CellaVision AB
STO:CEVI
3.5B SEK
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
193.5B USD
Loading...
Loading...
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
173.3B USD
Loading...
Loading...
Loading...
US
Stryker Corp
NYSE:SYK
135.2B USD
Loading...
Loading...
Loading...
IE
Medtronic PLC
NYSE:MDT
114.1B USD
Loading...
Loading...
Loading...
US
Boston Scientific Corp
NYSE:BSX
106.1B USD
Loading...
Loading...
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
43.7B EUR
Loading...
Loading...
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
Loading...
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
47.2B USD
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
46.2B USD
Loading...
Loading...
Loading...
US
Resmed Inc
NYSE:RMD
34B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
CellaVision AB Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
CellaVision AB
STO:CEVI
3.5B SEK
Loading...
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
193.5B USD
Loading...
Loading...
Loading...
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
173.3B USD
Loading...
Loading...
Loading...
Loading...
US
Stryker Corp
NYSE:SYK
135.2B USD
Loading...
Loading...
Loading...
Loading...
IE
Medtronic PLC
NYSE:MDT
114.1B USD
Loading...
Loading...
Loading...
Loading...
US
Boston Scientific Corp
NYSE:BSX
106.1B USD
Loading...
Loading...
Loading...
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
43.7B EUR
Loading...
Loading...
Loading...
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
Loading...
Loading...
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
47.2B USD
Loading...
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
46.2B USD
Loading...
Loading...
Loading...
Loading...
US
Resmed Inc
NYSE:RMD
34B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
CellaVision AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett